INTRODUCTION
Hepatitis B virus infection is one of the major global public health problem. HBV infection is the 10th leading cause of death and HBV related hepatocellular carcinoma (HCC) is the 5 th most frequent cancer worldwide. 1 About more than 2 billion of the world's population has serological evidence of past or recent HBV infection and there are more than 350 million chronic carriers of this infection. 2 Approximately 1 million persons die annually from HBV related chronic liver diseases including severe complications such as liver cirrhosis (LC) and hepatocellular carcinoma (HCC). 1 In India, HBsAg prevalence among the general population ranges from 2 to 8%, which places India in an intermediate endemic zone for HBV.
2,3 HBV infection is predominantly acquired at an early age in developing countries, which includes vertical transmission from mother to child, perinatal transmission, and horizontal transmission from child to child. However HBV can also be transmitted sexually (both homo and hetero sexual) accounts for a majority of the transmission occurring in adult life. 4 The clinical spectrum of HBV infection ranges from subclinical to acute symptomatic hepatitis or rarely fulminant hepatitis during the acute phase, inactive carrier state to chronic hepatitis. HBsAg is the first seromarker to indicate active HBV infection either acute or chronic. It would appear in patient's serum usually 2-10 weeks after being infected with HBV before liver enzymes are increased or clinical symptoms appear. In chronic HBV infection the HBsAg remains elevated for more than 6 months. 5 HBV circulates in high titres in blood and low titres in other body fluids and is hundred times more infectious than HIV infections and ten times more than HCV. 6 There are very few studies which are available regarding the prevalence of HBV among the patients in the southern part of Tamilnadu. Hence the present study was undertaken to estimate the seroprevalence of HBV in both sexes and different age groups in our hospital.
METHODS
The present study was carried out in patients attending outpatient and inpatient departments of our tertiary care hospital, Trichy, India.
These tests were done as part of preoperative screening, antenatal screening, screening on haemodialysis patients, on patients suspected to have HBV infection after getting a verbal consent. The sera were screened for the presence of HBsAg by a rapid test kit based on the principle of one step immunoassay (HEPACARDDiagnostic enterprises). Those found positive on screening test were confirmed by third generation ELISA kits (Hepalisa; J Mitra and Co. Pvt. Ltd., New Delhi, India) according to the manufacturers protocol. The results were analyzed using chi-square test.
RESULTS
Out of 19,513 individuals screened between 2010-2013, 315 (1.61%) were HBsAg positive. The age and sex wise distribution of individuals were shown in Table 1 
DISCUSSION
In the present study, the seroprevalence was found to be 1.61%. It was similar to that which was reported by other studies from Vellore district, Tamilnadu (1.7%), Rajasthan (0.87%), and Chennai (1.9%) (7, 8, 14) . In a study conducted in a hospital-based population at Kathmandu Medical College Hospital, Nepal, the prevalence rate was found to be 2.5%. 9 A study on the prevalence of HBsAg in patients attending a surgical OPD in Rawalpindi, Pakistan, reported 2.28%. 10 Chowdhury A reported that 3-4% of the Indian population are HBV infected with the highest prevalence among the aborigines of Andaman as well as from Arunachal Pradesh. 13 The prevalence of Hepatitis B varies from country to country and there is a wide variation in the prevalence in different regions of our country. The difference may be because of the type of population studied, different geographical region, genetic factors, health factors and socioeconomic status. In general, it is lowest in countries or areas with high standards of living like effective vaccination, improved sanitation and safe transfusion measures (e.g., Australia, North America, North Europe) and highest in countries or areas with low socioeconomic Levels (e.g., China, South East Asia, South America).
In our study, there was an increase in the prevalence among the male population as compared to that in females, as shown in table 1 and a majority of them belonged to the age group of 21-40 years, as shown in table 2. In accordance with our study, Dutta et al 11 and Sood S et al 8 also reported higher male preponderance. No possible explanation has been given for the higher prevalence in males in the general population but probably higher exposure to occupational HBV risk factors in man or else females clear the HBV more efficiently as compared to males. 12, 16 The incidence was highest among 21-40 years age group and lowest among 0-20 years. Thus these data indicate that the prevention of perinatally transmitted HBV in this locality by immunization and improvements in living standards of South Indian population. In contrast to our study, Singh J et al reported highest incidence among <5 years and then a progressive decline thereafter.
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CONCLUSION
To conclude, HBV causes a considerable disease burden in India with significant loss of human life. Therefore, India requires a suitable preventive strategy to target identified population groups. However, there are several gaps in the available epidemiological data that need to be addressed before a comprehensive policy can be devised for control of HBV infection in India.
However, an effective immunization programme is changing an epidemiological situation very fast with decrease in the prevalence as well as impact of HBV infection.
